Subcutaneous Olanzapine for Hyperactive or Mixed Delirium

Clinical trial NCT00512291 · COMPLETED

Trial details

NCT number: NCT00512291
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2005-06-01
Primary completion: 2007-08-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.